SEARCH

SEARCH BY CITATION

References

  • Arlander, E., A. Öst, D. Ståhlberg & R. Löfberg: Ropivacaine gel in active distal ulcerative colitis and proctitis – a pharmacokinetic and exploratory clinical study. Aliment. Pharmacol. Ther. 1996, 10, 7381.
  • Babbs, C. F.: Oxygen radicals in ulcerative colitis. Free Radic. Biol. Med. 1992, 13, 169181.
  • Björck, S., A. Dahlström & H. Ahlman: Topical treatment of ulcerative proctitis with lidocaine. Scand. J. Gastroenterol. 1989, 24, 10611072.
  • Björck, S., A. Dahlström, L. Johansson & H. Ahlman: Treatment of the mucosa with local anaesthetics in ulcerative colitis. Agents Actions, Special Conference Issue 1992,C60C72.
  • Björck, S., E. Jennische, A. Dahlström & H. Ahlman: Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats. Dig. Dis. Sci. 1997, 42, 824832.
  • Buell, M. G. & M.C. Berin: Neutrophil-independence of the initiation of colonic injury. Comparison of results from three models of experimental colitis in the rat. Dig. Dis. Sci. 1994, 39, 25752588.
  • Calkins, B. M.: A meta-analysis of the role of smoking in inflammatory bowel disease. Dig. Dis. Sci. 1989, 34, 18411854.
  • Cooper, H. S., S. N. S. Murthy, R. S. Shah & D. J. Soudergram: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993, 69, 238249.
  • De Boer, A. G., D. D. Breimer, H. Mattie, J. Pronk & J. M. Grubbens-Stibbe: Rectal bioavailability of lidocaine in man: partial avoidance of “first-pass” metabolism. Clin. Pharmacol. Ther. 1979, 26, 701709.
  • Dickstein, R., L. Kiremidjian-Schumacher & G. Stotzky: Effects of lidocaine on the function of immuno-competent cells. In vitro exposure of mouse spleen lymphocytes and peritoneal macrophages. Immunopharmacology 1985, 9, 117121.
  • Ekström, G. & U.-B. Gunnarsson: Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 IA and 3 A in human liver microsomes. Drug. Metab. Dispos. 1996, 29, 955961.
  • Ericksen, C.-J., J. Sjövall, H. Kehlet, C. Hedlund & T. Arvidsson: Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief. Anesthesiology 1996, 80, 834842.
  • Farmer, R. G.: In: Gastroenterology clinics of North America. W.B. Saunders Company, 1987, 16, pp. 168174.
  • Felten, D. L., S. Y. Felten, S. L. Carlsson, J. A. Olchowska & S. Livnat: Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 1985, 135, 755765.
  • Hickey, R., J. Blauchard, J. Hoffmann, J. Sjövall & S. Ramamurthy: Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block. Can. J. Anaesth. 1990, 37, 878882.
  • Jokinen, M. J., J. Ahonen, P. J. Nenvonen & K.T. Olkkola: Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine. Pharmacol. & Toxicol. 2001, 88, 187191.
  • Jönsson, A.: Burns and local anesthetics. Acad. Diss., University of Göteborg 1996,1119, ISBN 91–628–1979–8.
  • Knudsen, K., M. Beckman-Suurkula, S. Blomberg, J. Sjövall & N. Edvardsson: Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Brit. J. Anaesth. 1997, 78, 507514.
  • Kyösola, K., O. Penttilä & M. Salaspuro: Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand. J. Gastroenterol. 1977, 12, 363367.
  • Ley, K.: Molecular mechanisms of leukocyte recruitment in inflammatory process. Cardiovasc. Res. 1996, 32, 733742.
  • MacDonald, T. T. & S. H. Murch: Aetiology and pathogenesis of chronic inflammatory bowel disease. Ballieres Clin. Gastroenterol. 1994, 8, 134.
  • Martinsson, T., A. Haegerstrand & C.-J. Dalsgaard: Ropivacaine and lidocaine inhibit proliferation of non-transformed cultured adult human fibroblasts, endothelial cells and keratinocytes. Agents Actions 1993, 40, 7885.
  • Martinsson, T., T. Oda, E. Fernvik, K. Roempke, C.-J. Dalsgaard & E. Svensjö: Ropivacaine inhibits leukocyte rolling, adhesion and CD11b/CD18 expression. J. Pharmacol. Exp. Therap. 1997a, 283, 5965.
  • Martinsson, T., A. Haegerstrand & C.-J. Dalsgaard: Effects of ropivacaine on eicosanoid release from human granulocytes and endothelial cells in vitro. Inflamm. Res. 1997b, 46, 398403.DOI: 10.1007/s000110050210
  • Martinsson, T., T. Ljung, C. Rubio & P.M. Hellström: Beneficial effects of ropivacaine in rat experimental colitis. J Pharmacol. Exp. Therap. 1999, 291, 642647.
  • Mayer, L.: In: Antigen presentation in the gut. Immunology and immunopathology of the Liver and gastrointestinal tract. Eds: S. R.Targan & F.Shanahan. Igaku-Shoin Med. Publ, Inc. 1990, p. 3348.
  • Mazelin, L., V. Theodorou, J. More, J. Fioramonti & L. Bueno: Protective role of vagal afferents in experimentally-induced colitis in rats. J.Auton.Nerv.Syst. 1998, 73, 3845.
  • McCafferty, D.-M., K. A. Sharkey & J. L. Wallace: Beneficial effects of local or systemic lidocaine in experimental colitis. Amer. J. Physiol. 1994, 266, G560567.
  • McCafferty, D.-M., J. L. Wallace & K.A. Sharkey: Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Amer. J. Physiol. 1997, 272, G272280.
  • McClure, J. H.: Ropivacaine. Brit. J. Anaesth. 1996, 76, 300307.
  • Nash, S., C. Parkos, A. Nusrat, C. Delp & J. L. Madara: In vitro model of intestinal crypt abscess. A novel neutrophil-derived secretagogue activity. J. Clin. Invest. 1991, 87, 14741477.
  • Nusrat, A., C. A. Parkos, T. W. Liang, D. K. Carnes & J. L. Madara: Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. Gastroenterology 1997, 113, 14891500.
  • Pothoulakis, C, J. Castagliuolo, E. Mezey, H. Li, B. J. Hoffman, J. T. LaMont & S. Leeman: Increased substance-P and substance P receptor expression (mRNA SP-R) in Clostridium difficile toxin-A mediated enteritis in rats. Gastroenterology 1995, 108, A896.
  • Ramus, G. V., L. Cesano & A. Barbalonga: Different concentrations of local anaesthetics have different modes of action on human lymphocytes. Agents Actions 1983, 13, 333341.
  • Reinshagen, M., A. Patel, M. Sottili, S. French, C. Sternini & V.E. Eysselein: Action of sensory neurons in an experimental colitis model of injury and repair. Amer. J. Physiol. 1996, 270, G7986.
  • Riddell, R. H.: In: Inflammatory bowel disease. Ed.: J. B.Kirsner. Lea and Febiger, Philadelphia 1988, pp. 330335.
  • Ruetsch, Y. A., K. E. Fattinger & A. Borgeat: Ropivacaine-induced convulsions and severe cardiac dysrytenia after sciatic block. Anesthesiology 1999, 90, 17841786.
  • Sartor, R. B.: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment. Pharmacol. Ther. 1997, 11, 1722 (Review article).
  • Schreiber, S.: In: Aspects of the immunology of inflammatory bowel disease. Recent advances in the pathophysiology of gastro-intestinal and liver disease. Eds: J. P.Galmiche & J.Gournay. John Libbey Eurotext, Paris, 1997, pp. 133171.
  • Springer, T. A.: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradign. Cell 1994, 76, 301314.
  • Strichhartz, G.: Molecular mechanisms of nerve block by local anesthetics. Anesthesiology 1976, 45, 421441.
  • Taoka, S., T. Okahisa, M. Sogabe, S. Hayashi, H. Matunaga, Y. Ohkita, A. Tsutsui, T. Fukuda, N. Muguruma, M. Yasuda, T. Yokoi, S. Okamura, H. Shibata, S. Ho, T. Sano: Treatment with lidocaine gel enema for ulcerative colitis. Abstract 988. Proc. 5th United European Gastroenterology Week, 1996.
  • Tutton, P.J.M. & R.D. Helme: The influence of adrenoceptor activity on crypt cell proliferation in the rat jejunum. Cell. Tissue Kinet. 1974, 7, 125136.
  • Vilotte, J., D. Gargot, L. Siproudhis & M. Mignon: Tentative de traitement des rectites hemorragiques non specifiques (RHNS) par le gel de lidocaine administre par voie rectale. Gastroenterol. Cli. Biol. 1991, 15, A303.
  • Wulf, H., F. Worthmann, H. Behnke & A.S. Böhle: Pharmacokinetics and -dynamics of ropivacaine 2, 5 or 7.5 mg/nl after ilioinguinal blockade for inguinal hernia repair in adults. Anesth Analg. 1999, 89, 14711474.
  • Zahavi, I., J. Avidor & H. Marcus: Effects of sucralfate in experimental colitis in the rat. Gastroenterology 1987, 92, A1707.